Lupin launches biosimilar Etanercept in Canada
Rymti is indicated for the treatment of moderate to severe active rheumatoid arthritis, juvenile idiopathic arthritis, active and…
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Category
Market
Akums introduces DCGI approved FDC medication
Amlodipine, Telmisartan & Metoprolol (ER) film coated tablets for treatment of resistant Hypertension
Maiva Pharma raises Rs 1,000 cr from Morgan Stanley, India Life Sciences Fund
The proceeds will be used to set up a new manufacturing facility near Hosur with capabilities in sterile dosage forms
GLP-1R agonists clinical trial design needs to be improved to reassure drugs’ benefits: GlobalData
According to GlobalData, there are over 50 clinical trials for type 2 diabetes or obesity treatment involving GLP-1R agonists
IIT Bombay announces launch of 10X GMP facility
The facility will expedite the translation of academic research into innovative medical products, bridging the gap between…
Sanofi’s diabetes drug Soliqua launched in India
A once-daily solution that breaks through the complexity of living with type 2 diabetes
Granules India gets ANDA approval for Colchicine capsules
Colchicine Capsules are indicated for prophylaxis of gout flares in adults
Glenmark gets ANDA approval for Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg
Glenmark’s Acetaminophen and Ibuprofen Tablets, 250 mg/125 mg (OTC), will be distributed in the US by Glenmark Therapeutics, US
Enhertu shows positive results in DESTINY-Breast06 Phase III trial
Demonstrates statistically significant and clinically meaningful improvement in progression-free survival in HR-positive, HER2-low…
Lupin Digital Health’s Lyfe Platform gets Class C Medical Device License from CDSCO
First chronic condition management platform to be recognized as a Class C 'Software as a Medical Device'
AstraZeneca’s Lynparza to dominate PARP inhibitors market with $4 bn in sales by 2027: GlobalData
Most of Lynparza’s sales come from ovarian and HER2-negative breast cancer treatment
New Drug Application of Zydus’ Desidustat tablets by China Medical System Holdings accepted in China
Desidustat, administered orally is a novel, oral Hypoxia-Inducible Factor-Prolyl Hydroxylase Inhibitor (HIF-PHI) for treating…
Top 20 global biopharma companies report 9.6 per cent market cap growth in Q1 2024: GlobalData
it went from $3.67 trillion as on 31 December 2023 to $4 trillion as on 31 March 2024
Zydus launches Mirabegron ER tablets in US
Mirabegron is indicated for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and…
Dr. Reddy’s launches condition management programme, DailyBloom IBS
It is a digital integrated care plan to manage Irritable Bowel Syndrome
Biocon signs licensing and supply pact with Biomm S.A for Semaglutide commercialisation in Brazil
Semaglutide (gOzempic), which is used to improve glycemic control in adults with type-2 diabetes
ENTOD Pharma gets CDSCO approval for eye drops to treat presbyopia
Clinical trials have demonstrated PresVu's efficacy in enhancing close-up vision within minutes of application
MASH innovator drug partnerships surge over $2.5 bn in 2024YTD: GlobalData
MASH drugs secured over $5.7 billion in total partnership deal value from 2018 to 2024YTD, where 2024YTD is already the top year…
Amneal launches PEMRYDI RTU, ready-to-use version of pemetrexed, oncology injectable medicine
PEMRYDI RTU injectable is available in two vial sizes: 100mg/10mL and 500 mg/50mL
Gilead Sciences announces $4 mn ALL4LIVER grant for viral hepatitis elimination by 2030
Indian organisations Chennai Liver Foundation and FIND receive the grant